# Study of VIR-2482 in Healthy Volunteers

> **NCT04033406** · PHASE1 · COMPLETED · sponsor: **Vir Biotechnology, Inc.** · enrollment: 100 (actual)

## Conditions studied

- Influenza A

## Interventions

- **DRUG:** VIR-2482
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04033406
- **Lead sponsor:** Vir Biotechnology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-26
- **Primary completion:** 2021-11-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04033406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04033406, "Study of VIR-2482 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04033406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*